| Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial J Kubica, P Adamski, M Ostrowska, J Sikora, JM Kubica, WD Sroka, ... European Heart Journal 37 (3), 245-252, 2015 | 321 | 2015 |
| Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors J Kubica, A Kubica, B Jilma, P Adamski, EL Hobl, EP Navarese, ... International Journal of Cardiology 215, 201-208, 2016 | 93 | 2016 |
| Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors P Adamski, M Koziński, M Ostrowska, T Fabiszak, EP Navarese, ... Thrombosis and haemostasis 112 (08), 224-242, 2014 | 58 | 2014 |
| Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized … J Kubica, P Adamski, M Ostrowska, M Koziński, K Obońska, E Laskowska, ... Trials 16, 1-6, 2015 | 41 | 2015 |
| Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts’ standpoint J Kubica, P Adamski, P Paciorek, JR Ładny, Z Kalarus, W Banasiak, ... Cardiology journal 25 (3), 291-300, 2018 | 39 | 2018 |
| PCSK9 inhibition during the inflammatory stage of SARS-CoV-2 infection EP Navarese, P Podhajski, PA Gurbel, K Grzelakowska, E Ruscio, ... Journal of the American College of Cardiology 81 (3), 224-234, 2023 | 37 | 2023 |
| Stratified approaches to antiplatelet therapies based on platelet reactivity testing M Ostrowska, J Kubica, P Adamski, A Kubica, C Eyileten, M Postula, ... Frontiers in cardiovascular medicine 6, 176, 2019 | 36 | 2019 |
| New directions for pharmacotherapy in the treatment of acute coronary syndrome P Adamski, U Adamska, M Ostrowska, M Koziński, J Kubica Expert Opinion on Pharmacotherapy 17 (17), 2291-2306, 2016 | 34 | 2016 |
| Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A … P Adamski, J Sikora, E Laskowska, K Buszko, M Ostrowska, JM Umińska, ... PLOS ONE 12 (10), e0186013, 2017 | 33 | 2017 |
| Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled … J Kubica, P Adamski, K Buszko, M Barańska, J Sikora, MP Marszałł, ... European Heart Journal-Cardiovascular Pharmacotherapy 5 (3), 139-148, 2019 | 32 | 2019 |
| Metabolism of ticagrelor in patients with acute coronary syndromes P Adamski, K Buszko, J Sikora, P Niezgoda, M Barańska, M Ostrowska, ... Scientific Reports 8, 11746, 2018 | 32 | 2018 |
| Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study J Kubica, P Adamski, K Buszko, A Kubica, W Kuliczkowski, T Fabiszak, ... European Heart Journal - Cardiovascular Pharmacotherapy 4 (3), 152-157, 2017 | 32 | 2017 |
| Impact of COVID‐19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV‐HF‐SIRIO 6 study) J Kubica, M Ostrowska, W Stolarek, M Kasprzak, K Grzelakowska, J Kryś, ... ESC heart failure 9 (1), 721-728, 2022 | 31 | 2022 |
| Basic laboratory parameters as predictors of in-hospital death in patients with acute decompensated heart failure: data from a large single-centre cohort M Ostrowska, A Ostrowski, M Łuczak, M Jaguszewski, P Adamski, ... Kardiologia Polska (Polish Heart Journal) 75 (2), 157-163, 2017 | 27 | 2017 |
| Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor P Adamski, K Buszko, J Sikora, P Niezgoda, T Fabiszak, M Ostrowska, ... Scientific Reports 9 (1), 3924, 2019 | 26 | 2019 |
| Anti-aggregation therapy in patients with acute coronary syndrome—recommendations for medical emergency teams. Experts’ standpoint J Kubica, P Adamski, P Paciorek, JR Ładny, Z Kalarus, W Banasiak, ... Kardiologia Polska (Polish Heart Journal) 75 (4), 399–408, 2017 | 26 | 2017 |
| Evaluating current and emerging antithrombotic therapy currently available for the treatment of acute coronary syndrome in geriatric populations P Adamski, U Adamska, M Ostrowska, EP Navarese, J Kubica Expert Opinion on Pharmacotherapy, 2018 | 22 | 2018 |
| Impact of mild therapeutic hypothermia on bioavailability of ticagrelor in patients with acute myocardial infarction after out-of-hospital cardiac arrest JM Umińska, J Ratajczak, K Buszko, P Sobczak, W Sroka, MP Marszałł, ... Cardiology Journal 27 (6), 780-788, 2020 | 21 | 2020 |
| The rationale for multilevel educational and motivational intervention in patients after myocardial infarction (MEDMOTION) project is to support multicentre randomized clinical … A Kubica, P Adamski, A Bączkowska, D Czarnecki, T Derewiecki, ... Medical Research Journal 5 (4), 244-249, 2020 | 20 | 2020 |
| Off-target effects of glycoprotein IIb/IIIa receptor inhibitors M Ostrowska, P Adamski, M Koziński, EP Navarese, T Fabiszak, G Grześk, ... Cardiology journal 21 (5), 458-464, 2014 | 19 | 2014 |
